TY - JOUR
T1 - Coordinated responses of glucogenic hormones to central glucopenia
T2 - the role of the sympathoadrenal system.
AU - Cryer, P. E.
N1 - Funding Information:
The author's work cited was supported by U.S.P.H.S. grants AM 27085, AM 20579 and RR 00036.
PY - 1983
Y1 - 1983
N2 - In normal humans glucagon plays a primary role in promoting glucose recovery from hypoglycemia, glucagon deficiency is largely compensated for by enhanced epinephrine secretion, and recovery from hypoglycemia fails to occur only in the absence of both glucagon and epinephrine. Defective glucose counterregulation is exemplified by patients with insulin-dependent diabetes. Although most such patients have deficient glucagon secretory responses to hypoglycemia, they counterregulate adequately because of intact epinephrine secretion. Some patients, however, become defenseless against hypoglycemia because of combined deficiencies of glucagon and epinephrine.
AB - In normal humans glucagon plays a primary role in promoting glucose recovery from hypoglycemia, glucagon deficiency is largely compensated for by enhanced epinephrine secretion, and recovery from hypoglycemia fails to occur only in the absence of both glucagon and epinephrine. Defective glucose counterregulation is exemplified by patients with insulin-dependent diabetes. Although most such patients have deficient glucagon secretory responses to hypoglycemia, they counterregulate adequately because of intact epinephrine secretion. Some patients, however, become defenseless against hypoglycemia because of combined deficiencies of glucagon and epinephrine.
UR - http://www.scopus.com/inward/record.url?scp=0021006723&partnerID=8YFLogxK
U2 - 10.1016/b978-0-12-027310-2.50025-6
DO - 10.1016/b978-0-12-027310-2.50025-6
M3 - Review article
C2 - 6364722
AN - SCOPUS:0021006723
SN - 0065-2903
VL - 10
SP - 469
EP - 483
JO - Advances in metabolic disorders
JF - Advances in metabolic disorders
ER -